Adapsyn Bioscience Inc.
Hamilton, Ontario, Canada
Purpose
to isolate novel GH drugs from bacteria by mining biosynthetic gene clusters associated with self-resistance genes leading to new drugs to benefit those in the developing world infected with global health pathogens, such as TB and malaria
Division
Global Health
Date
September 2022
Region Served
GLOBAL
Committed amount
$1,237,639
Grant topic
Create Novel Technology Platform Capabilities
Duration (months)
21
Grantee location
Hamilton, Ontario, Canada
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.